Takeda Pharmaceutical
TAK
$13.24
Share price
0.61%
Change (1 day)
-20.43%
Change (1 year)
Categories
Takeda Pharmaceutical (TAK) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $53.07 B
According to Takeda Pharmaceutical's latest financial reports the company's total liabilities are $53.07 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Takeda Pharmaceutical - Total liabilities on balance sheet (from 2008 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-03-31 | $57.07 B | -7.07% |
| 2022-03-31 | $61.41 B | -12.41% |
| 2021-03-31 | $70.12 B | -6.4% |
| 2020-03-31 | $74.91 B | -3.39% |
| 2019-03-31 | $77.54 B | 294.61% |
| 2018-03-31 | $19.65 B | -8.4% |
| 2017-03-31 | $21.45 B | 32.96% |
| 2016-03-31 | $16.13 B | -7.36% |
| 2015-03-31 | $17.41 B | -11.67% |
| 2014-03-31 | $19.71 B | 8.43% |
| 2013-03-31 | $18.18 B | 4.75% |
| 2012-03-31 | $17.35 B | 122.13% |
| 2011-03-31 | $7.81 B | 10.97% |
| 2010-03-31 | $7.04 B | -1.34% |
| 2009-03-31 | $7.13 B | 35.29% |
| 2008-03-31 | $5.27 B | 1.61% |
| 2007-03-31 | $5.19 B | -11.89% |
| 2006-03-31 | $5.89 B | 16.04% |
| 2005-03-31 | $5.07 B | -4.6% |
| 2004-03-31 | $5.32 B | 27.76% |
| 2003-03-31 | $4.16 B | 1.88% |
| 2002-03-31 | $4.08 B | 4.05% |
| 2001-03-31 | $3.92 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $98.78 B | 86.14% | 🇺🇸 USA |
 Novartis NVS | $53.19 B | 0.24% | 🇨🇭 Switzerland |
 Pfizer PFE | $137.21 B | 158.55% | 🇺🇸 USA |
 Amgen AMGN | $90.92 B | 71.32% | 🇺🇸 USA |
 Sanofi SNY | $57.61 B | 8.56% | 🇫🇷 France |
 Merck MRK | $69.04 B | 30.09% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $58.82 B | 10.84% | 🇬🇧 UK |
 Seagen
SGEN | $1.08 B | -97.96% | 🇺🇸 USA |
 Dr. Reddy's RDY | $1.26 B | -97.62% | 🇮🇳 India |